Estructura del grupo
11 empresas en 6 países
Cargando la página…
Cargando la página…
11 empresas en 6 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 118
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| DUACGel | Clindamycin, Benzoyl peroxide | Italia | Autorizado | |
| DUAC5%; 1.2% · GEL | Benzoyl peroxide, Clindamycin | Estados Unidos | Comercializado | 2002 |
| Duac Acne Gel 10 mg/g + 50 mg/g, gelGel | Benzoyl peroxide, Clindamycin | Países Bajos | Autorizado | 2005 |
| SCABENE1% · Lotion | Lindane | Estados Unidos | No comercializado | |
| SCABENE1% · Shampoo | Lindane | Estados Unidos | No comercializado | |
| SORIATANE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG **Federal Regist · Capsule | Acitretin | Estados Unidos | No comercializado | 1996 |
| TOCTINOCapsula molle | Alitretinoin | Italia | Autorizado | |
| Toctino 10 mg, capsules, zachtCapsule, zacht | Alitretinoin | Países Bajos | Autorizado | 2009 |
| Toctino 30 mg, capsules, zachtCapsule, zacht | Alitretinoin | Países Bajos | Autorizado | 2009 |
| clindoxyl control | Brasil | Autorizado | 2012 | |
| CLINDOXYL CONTROL | Brasil | Autorizado | 2018 | |
| CLINDOXYL CONTROL | Brasil | Autorizado | 2018 | |
| CLINDOXYL CONTROL | Brasil | Autorizado | 2015 | |
| clindoxyl control | Brasil | Autorizado | 2017 | |
| clindoxyl control | Brasil | Autorizado | 2012 | |
| clindoxyl control | Brasil | Autorizado | 2017 | |
| clindoxyl control | Brasil | Autorizado | 2015 | |
| clindoxyl control | Brasil | Autorizado | 2015 | |
| CLINDOXYL CONTROL | Brasil | Autorizado | 2015 | |
| CLINDOXYL CONTROL 10% | Brasil | Autorizado | 2015 | |
| ISOTREX GEL 0.05% | Isotretinoin | Arabia Saudí | Autorizado | |
| ISOTREXIN GEL | Erythromycin, Isotretinoin | Arabia Saudí | Autorizado | |
| PANOXYL 10 ACNE GEL | Benzoyl peroxide | Arabia Saudí | Autorizado | |
| PANOXYL 5 ACNE GEL | Benzoyl peroxide | Arabia Saudí | Autorizado | |
| PANOXYL 5 LOTION | Benzoyl peroxide | Arabia Saudí | Autorizado |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Brasil | 68 | 13 | 55 | EmpresasTodos los medicamentos |
| Canadá | 29 | 0 | 29 | EmpresasTodos los medicamentos |
| Arabia Saudí | 8 | 8 | 0 | EmpresasTodos los medicamentos |
| España | 4 | 0 | 4 | EmpresasTodos los medicamentos |
| Estados Unidos | 4 | 4 | 0 | EmpresasTodos los medicamentos |
| Países Bajos | 3 | 3 | 0 | EmpresasTodos los medicamentos |
| Italia | 2 | 2 | 0 | EmpresasTodos los medicamentos |
También en los registros de Francia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Stiefel en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaLicencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.